The rapamycin-regulated gene expression signature determines prognosis for breast cancer

BACKGROUND: Mammalian target of rapamycin (mTOR) is a serine/threonine kinase involved in multiple intracellular signaling pathways promoting tumor growth. mTOR is aberrantly activated in a significant portion of breast cancers and is a promising target for treatment. Rapamycin and its analogues are...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Akcakanat, Argun, Zhang, Li, Tsavachidis, Spiridon, Meric-Bernstam, Funda
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2009
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2761377/
https://ncbi.nlm.nih.gov/pubmed/19778445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-8-75
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller